Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Abatacept in Rheumatoid Arthritis Participants
- Status
- COMPLETED
- Phase
- N/A
A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
INTERVAL: Ipilimumab and Nivolumab Combination Therapy: A Study of a Supervised or Semi-Supervised Exercise InteRVention or Usual Care With Functional Capacity and Quality of Life Evaluations in Subjects With Advanced or Metastatic RenAL Cell Carcinoma
- Status
- TERMINATED
- Phase
- NA
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
- Status
- COMPLETED
- Phase
- PHASE2
API-CAT STUDY for APIxaban Cancer Associated Thrombosis
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
IPD in RRMM Characterized with Genomic Abnormalities of Adverse Prognostic
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents
- Status
- COMPLETED
- Phase
- N/A